Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone
- 1 July 2020
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 128 (6) , 1591-1595
Abstract
Objective: The aim of the present study was to evaluate oxidative stress state in non-alcoholic fatty liver (NAFLD) patients at the time of diagnosis and by passing three months from the treatment. Methods: 37 patients with NAFLD in summer 2019 were enrolled in this study. Also, 37 healthy controls that were matched for sex and age were included as a control group. Oxidative stress parameters such as lipid peroxidation (MDA), total antioxidant capacity (TAC), and Thiols were measured by standard methods and were then compared with before treatment. Results: At the time of diagnosis, MDA levels were significantly increased and FRAP and Thiol levels were significantly decreased. After 3 months of treatment with pioglitazone, MDA levels decreased and FRAP and Thiol group increased. Conclusions: Non-alcoholic fatty liver disease is associated with the higher levels of MDA and lower serum levels of total antioxidant capacity and Thiol group levels.Keywords
This publication has 22 references indexed in Scilit:
- Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?Gastroenterology, 2016
- Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat LoadInternational Journal of Molecular Sciences, 2016
- Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?Oxidative Medicine and Cellular Longevity, 2016
- How to Diagnose Nonalcoholic Fatty Liver DiseaseDigestive Diseases, 2016
- Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver diseaseFree Radical Research, 2015
- Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nashTurkish Journal of Gastroenterology, 2015
- Biomarkers of NAFLD progression: a lipidomics approach to an epidemicJournal of Lipid Research, 2015
- Non-alcoholic fatty liver disease: What the clinician needs to knowWorld Journal of Gastroenterology, 2014
- Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral HepatitisJournal of Clinical and Experimental Hepatology, 2013
- Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatinArab Journal of Gastroenterology, 2011